Nevsun Resources About To Put More Money In Your Pocket (NSU)

Looking at the universe of stocks we cover at Dividend Channel, on 9/26/14, Nevsun Resources Ltd. (NSU) will trade ex-dividend, for its quarterly dividend of $0.035, payable on 10/15/14. As a percentage of NSU's recent stock price of $3.68, this dividend works out to approximately 0.95%, so look for shares of Nevsun Resources Ltd. to trade 0.95% lower — all else being equal — when NSU shares open for trading on 9/26/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for NSU, showing historical dividends prior to the most recent $0.035 declared by Nevsun Resources Ltd.:

NSU+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from NSU is likely to continue, and whether the current estimated yield of 3.80% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of NSU shares, versus its 200 day moving average:

Nevsun Resources Ltd. 200 Day Moving Average Chart

Looking at the chart above, NSU's low point in its 52 week range is $3.00 per share, with $4.33 as the 52 week high point — that compares with a last trade of $3.68.

In Wednesday trading, Nevsun Resources Ltd. shares are currently down about 0.5% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says